LifeMD appoints Dr. Calum MacRae, Harvard cardiologist, to board

LifeMD, Inc.

Dr. MacRae appointed as independent director effective April 26, 2024.
He is Vice Chair for Scientific Innovation, Brigham and Women's Hospital, and Harvard professor.
Compensation: 50,000 restricted shares vesting in three annual tranches through 2027.
MacRae's expertise includes cardiology, virtual care, and chronic disease management.
Press release issued April 29, 2024; no other material changes reported.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Calum MacRae

Member of the Board of Directors

LFMD · LifeMD, Inc.

Effective: 2024-04-26
Filed: May 2, 2024, 7:59 PM ET

On April 26, 2024, Calum MacRae was appointed to the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Calum MacRae was appointed as Member of the Board of Directors at LifeMD, Inc..

Action: appointed
Role: Member of the Board of Directors

Exact text from the filing

On April 26, 2024, Calum MacRae was appointed to the Board of Directors.

View on SEC.gov

LifeMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-017571

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.